New Men B immunisation advice

Following recent high profile stories about child deaths from meningitis B, Public Health England has issued further advice:

Men B immunisation programme

Following recent media coverage about the death of a young girl from invasive meningococcal disease caused by Men B, many GP practices have had queries from parents about the availability of Men B immunisation. 

This information is taken from Public Health England publications and the GOV.UK website (see below for details).

What is the national policy for Men B immunisation?

The Men B immunisation programme started on 1 September 2015 for babies aged 2 months, ie, babies born on or after 1 July 2015.  There was a limited catch-up programme for babies born on or after 1 May 2015.  The routine schedule is for immunisation to be given at 2 and 4 months with the primaries, with a booster at 12 months.

Can I vaccinate children born before 1 May 2015 if parents request it? 

No. The national stock of Bexsero® should only be used to vaccinate children who are eligible for NHS vaccination.

Can I vaccinate children born on or after 1 May 2015 who have not yet been vaccinated?

Yes.  All children in the eligible cohort (ie, born on or after 1 May 2015) remain eligible for Men B immunisation until the age of two years. When Bexsero® has not been given as part of a primary course, give two doses at least two months apart. Those children who have received one dose before their first birthday only require one more dose. Please see the MenB PGD for more information.

If parents ask to pay for Men B immunisation for their children, what should I tell them?

GPs should not charge their own patients (ie, those registered at their practice) a private fee for the vaccine.

Parents seeking the vaccine privately should be made aware that they will be liable for the full costs of the vaccine and any additional administration charges that the private provider may apply. We understand that GSK has supply constraints on the Bexsero vaccine for the private market. Practices must not use centrally-procured stock for the national programme to vaccinate private patients or any patients outside the eligible cohort (other than those at high risk as defined in the green book).

Further information

Last updated : 16 Mar 2016

 

Responsible Oxygen Prescribing (04 Sep 2015)

The London Respiratory Network have asked us to re-circulate a copy of the London Clinical Oxygen Network (LCON) key messages for Responsible Oxygen use in adults...
Read more »

August Newsletter (13 Aug 2015)

Londonwide LMCs Newsletter
Read more »

Making health and social care information accessible (12 Aug 2015)

The new Accessible Information Standards for GP Practices has been launched by NHS England and comes into force on 31 July 2016.  Practices must ensure that all information...
Read more »

Men ACWY – Sign up guidance and Action Card for GPs from NHS England (12 Aug 2015)

Following enquiries received from practices regarding the Men ACWY programme, NHS England has issued brief guidance about the sign up process for this...
Read more »

GMS global sum calculation and data request for atypical population profiles (12 Aug 2015)

The BMA have produced a document that details how the global sum allocation (Carr-Hill formula) determines funding for GMS practices. This has been published in response to...
Read more »

PHP Reflective Practice Master Classes beginning 12 September 2015 (12 Aug 2015)

Each Master Class helps individuals to identify both the organisational and psychological barriers to change and personal development. Participants will have the choice of attending one of the following...
Read more »

Friends and Family Test: Disappointing news for London practices (12 Aug 2015)

Although it is a contractual requirement for practices to carry out the Friends and Family Test (F&FT) and submit data each month, the May return for London was a disappointing...
Read more »

New pan-London Cervical Sample Taker Database (CTSD) (12 Aug 2015)

NHS England has commissioned a web-based Cervical Sample Taker Database (CSTD) for the quality assurance of sample taking in London. The database enables the allocation of unique sample taker codes...
Read more »
Next Page »
« Previous Page